John A. Johnson, MD, MBA: Statins are medications that are used to lower cholesterol. They come with a lot of side effects; namely, the potential for causing damage, or injury, to the liver and muscle injury—so myopathy and rhabdomyolysis. A lot of these conditions can sometimes be painful and harmful. What we recommend, when a patient is started on a statin, is that they receive regular touchpoints with their clinician to ensure that their liver function tests are assessed, so that none of these negative events are occurring. Likewise, we want to ensure that our members are tolerating the medication and that it’s efficacious (meaning that it’s lowering the LDL [low-density lipoprotein] as the clinician would like it to).
Because these medications have a lot of side effects and safety concerns, sometimes the public tends to be a bit afraid of them. [However], the medications have been around for quite some time, and they’ve actually been proven to be very successful in lowering the LDL and lowering the risk of cardiovascular events, such as stroke. We definitely support, at WellCare, the use of statins, and we make these medications available on our preferred drug list.
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Semaglutide Linked to Cardiovascular Gains, but Also Higher Health Spending
August 8th 2025A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and cholesterol, but also a $80 monthly rise in health care spending outside of drug costs.
Read More
Immune Checkpoint Inhibitors More Effective vs Bevacizumab in Nonsquamous NSCLC
August 6th 2025Bevacizumab combined with chemotherapy was not as effective in advanced driver gene-negative nonsquamous non–small cell lung cancer (NSCLC) compared with immune checkpoint inhibitors plus chemotherapy.
Read More